Effect of oral vitamin C on serum hepcidin level, iron status and inflammation among hemodialysis patients with functional iron deficiency anaemia
Journal of Renal Endocrinology · 14.08.2021 · 7 (1) · e16-e16
DOI: 10.34172/jre.2021.16 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Renal Endocrinology, online erschienen am 14.08.2021. Verfasst von Maha A. Behairy und 3 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref).
Abstract (Originalsprache)
Introduction
Hepcidin is a key regulatory peptide in iron homeostasis, the pathogenesis of functional iron deficiency (FID) anemia and erythropoiesis-stimulating agent (ESA) resistance is contributed to the inflammatory mediated increase in the serum hepcidin levels among prevalent hemodialysis (HD) patients.
Objectives
To test the reducing therapeutic effect of oral vitamin C supplements on hepcidin levels and iron status among HD patients with FID anemia. Patients and Methods: This study is an interventional prospective cohort study; 48 prevalent HD patients were enrolled. Group one: 31 patients who received the conventional treatment of erythropoietin stimulating agents together with oral supplementation of vitamin C 500 mg every other day dose for 3 months. Group two: 17 patients who received only the conventional therapy of erythropoietin stimulating agents. Patients with hemoglobin level 200 ng/mL and transferrin saturation (TSAT) >20 % were included. Laboratory parameters: serum hepcidin, high-sensitivity C-reactive protein (hs-CRP) titre, CBC, and iron indices were measured at baseline and after 3 months.
Results
On comparing the two groups, oral vitamin C in group 1 resulted in a statistically significant reduction in hepcidin levels [mean 2506.456 ± 1320.53 pg/mL to 1748.396 ± 1432.28 pg/mL (P = 0.03)], and a significant reduction in hs-CRP level [mean 8603.236 ± 2547.77 ng/mL to 5611.296 ± 2829.27 ng/mL] (P = 0.001) after three months of treatment in comparison to control group. A decrease of EPO requirement and elevation of hemoglobin level were observed in a study group with oral vitamin C.
Conclusion
Oral vitamin C may be a promising therapy in decreasing serum hepcidin and inflammatory markers among prevalent HD patients with FID anemia.
Zitieren
APA
Behairy, M. A., Gharib, A., Zaki, M., & Sharabasy, R. E. (2021). Effect of oral vitamin C on serum hepcidin level, iron status and inflammation among hemodialysis patients with functional iron deficiency anaemia. Journal of Renal Endocrinology, 7(1), e16-e16. https://doi.org/10.34172/jre.2021.16
Vancouver
Behairy MA, Gharib A, Zaki M, Sharabasy RE. Effect of oral vitamin C on serum hepcidin level, iron status and inflammation among hemodialysis patients with functional iron deficiency anaemia. Journal of Renal Endocrinology. 2021;7(1):e16-e16. doi:10.34172/jre.2021.16
BibTeX
@article{Behairy2021,
author = {Behairy, Maha A. and Gharib, Ahmed and Zaki, Mahmoud and Sharabasy, Reem El},
title = {Effect of oral vitamin C on serum hepcidin level, iron status and inflammation among hemodialysis patients with functional iron deficiency anaemia},
journal = {Journal of Renal Endocrinology},
year = {2021},
volume = {7},
number = {1},
pages = {e16--e16},
doi = {10.34172/jre.2021.16}
}
EUVIMED